AI Drug Interaction Checker: What the Best AI for Drug Interactions Actually Checks

The short answer: An AI drug interaction checker is not one thing. It is either a general chatbot that will happily discuss drug interactions with no clinical database behind it, or a purpose-built tool that runs a structured check against maintained pharmacology data and uses a language layer to accept messy input and explain the result. The first is a conversation. The second is a check. Telling them apart before you rely on one is the whole job.

The confusion is understandable. Both give you a fluent paragraph in a couple of seconds, and the fluent paragraph looks the same either way. What differs is whether anything was actually looked up, and whether the tool will tell you about the interaction you did not think to ask about. This piece sets out what a real AI interaction check does, where the language model genuinely earns its place, and the questions worth asking a vendor before you put a medication list into anything.

What is an AI drug interaction checker?

In practice the label covers two very different products. The first is a general assistant, ChatGPT or Claude or Gemini, being asked a drug question. There is no pharmacology dataset underneath it. The model reproduces what it absorbed from the text it was trained on, which for well-documented pairs is often correct and for the long tail is a guess delivered in the same confident register.

The second is a clinical tool that keeps a maintained interaction dataset and puts a language layer on top of it. The AI is doing something narrower and more useful there: reading a medication list that arrived as free text, resolving brand names and misspellings to the right ingredient, and turning a database hit into a sentence a busy clinician can act on. The lookup is still a lookup. The model handles the mess at either end.

That second design is what most clinicians mean when they say they want AI in the workflow. They are not asking a model to know pharmacology from memory. They are asking it to stop making them retype a medication list into a form with eight autocomplete fields.

Can ChatGPT check drug interactions?

It will answer, and answering is not checking. Ask about warfarin and clarithromycin and you will get a good response, because that pair appears in a great deal of published text. Ask about a combination that is genuinely uncommon and the same tool produces the same confident prose with far less behind it, and nothing in the output distinguishes the two cases.

The more important limitation is what it does not volunteer. A general model tends to answer the question you asked. Paste eleven medications and ask whether it is safe to add a twelfth, and it will address the twelfth. The interaction sitting between drug four and drug nine, the one that has been there for months and that nobody has looked at, does not come up because nobody asked. Missed interactions are overwhelmingly of that kind. We go through the distinction in more detail in OpenEvidence vs ChatGPT, where the same gap shows up between a general assistant and a purpose-built clinical tool.

There is also a compliance problem that has nothing to do with accuracy. OpenAI offers a HIPAA Business Associate Agreement for ChatGPT Enterprise, ChatGPT Edu and its API, and states that it does not offer one for ChatGPT Business. The consumer tiers are not covered either. So the version of ChatGPT most clinicians actually have open is a place where patient details should not go, whatever you think of the clinical answer.

What does the best AI for drug interactions actually check?

A tool worth relying on runs more than one check, because interactions are only one of the ways a prescription goes wrong. When you are comparing options, this is the list to hold them against.

Two of those deserve particular attention because standalone checkers routinely skip them. Drug-disease interactions never fire in a tool that only asks you to enter medications, since the condition was never an input. And renal dosing goes wrong in a specific, predictable way: most US labels state their thresholds by Cockcroft-Gault creatinine clearance in mL/min, while the eGFR your lab auto-reports is CKD-EPI indexed to 1.73 square meters. They are not interchangeable, and the gap is widest in exactly the patients where dosing matters most, the very small, the very large, the elderly and those with low muscle mass. A tool that quietly treats one number as the other will be wrong without ever looking uncertain.

Where AI genuinely helps

The honest case for AI here is not that it knows more pharmacology. It is that it removes the two frictions that cause checks to be skipped.

The first is input. Real medication lists arrive as a paragraph in a referral letter, a photographed pill bottle list, a patient reciting what they think they take. Structured checkers demand a clean list, so somebody has to build one, and when the clinic is running forty minutes behind, that step is what gets dropped. A language layer that accepts the paragraph and resolves it to ingredients turns a three-minute chore into a paste.

The second is output. Traditional interaction checkers are notorious for firing on everything, and clinicians override the overwhelming majority of what they see. That is not laziness, it is a rational response to a signal-to-noise problem, and it is the core failure mode described in the literature on EHR drug interaction alerts. A model that can rank by clinical significance and explain why this flag matters for this patient is doing something a rules engine cannot, and it is the difference between an alert that gets read and one that gets clicked through.

Neither of those requires the model to be the source of truth. That is the design principle worth insisting on: the data comes from maintained clinical references, and the AI handles the language at both ends.

What to ask before trusting an AI tool with a medication list

Five questions separate the serious tools from the demos, and all five have concrete answers a vendor should be able to give you in writing.

Where does the data come from? A named clinical pharmacology source, or the model's training data? If the vendor cannot name the reference, the model is the reference, and you are the quality control.

Is every flag cited? You need to be able to open the source and confirm before you act. A flag you cannot verify is a flag you cannot defend.

Does it check unprompted? Does it sweep the whole list, or only answer the question you typed? This is the single biggest practical difference between a chat window and a checker.

What is the BAA position? Which specific product tier is covered, not which company has a compliance page. Vendors frequently offer an agreement on the enterprise tier and not on the one you are using, and that distinction is where organizations get caught. It is the same category of question as the guardrails on what an AI tool is allowed to do with your data that any team should settle before wiring a model into a real workflow.

What does it claim to do? Decision support flags things for a clinician to review. Anything presenting itself as making the call is claiming something different, and you should read that claim carefully.

The verification rule that does not change

Whatever tool you use, the output is a prompt for your judgment rather than a conclusion. Class-level guidance does not settle a specific patient, an absent flag is not proof of safety, and current labeling is the authority when a tool and a label disagree. That has always been true of interaction checkers. Adding a language model to the front of one does not alter it, and any vendor implying otherwise is telling you something useful about the vendor.

What a good tool changes is how many of the checks actually happen. If running interactions, contraindications, allergy cross-reactivity and renal dosing takes four separate lookups, some of them will not happen on a bad afternoon. If it takes one, they will. That is the entire argument for AI clinical decision support at the point of prescribing, and it is a workflow argument rather than an intelligence one.

Prescriber.io is built on that principle. Enter the drug or the scenario once and it checks drug-drug interactions, flags contraindications and allergy blockers, surfaces renal and hepatic dose adjustments and suggests guideline-based alternatives, together, in a single card with sources cited on each flag. It is decision support for licensed clinicians, not autonomous prescribing. You review every flag, verify against official sources, and sign. If you want the underlying capability on its own, the drug interaction checker is the place to start.